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A primary function of epithelial and endothelial monolayers is the formation of barriers that
separate tissues into functional compartments. Tight junctions (TJs) seal the intercellular
space between the single cells of a monolayer. TJs thus contribute importantly to
the homeostasis of the cerebrospinal fluid as they help in maintaining the blood-
brain barrier (BBB) and the blood-cerebrospinal fluid barrier (CSF). The composition
of TJs differs by its localization as well as the stage of development according to its
respective function. Claudin-3 is typically present in the epithelia and has been claimed
to be a constituent of the BBB. It is, however, notoriously difficult to demonstrate
its expression in endothelial cells of the brain vasculature at the morphological level
by means of immunohistochemical techniques. Using an improved fixation strategy
(4% paraformaldehyde at pH 11, in the presence of EDTA) and the sensitive alkaline
phosphatase as a detection system, we show that claudin-3 is present in mouse epithelia
from embryonic day 14 onwards. In brain, it is restricted to the anlage of choroid plexus
in the ventricles, together with claudin-1 and -2. In adult mice, it is clearly delineating the
epithelium of the choroid plexus in the lateral and fourth ventricles. In contrast, in cerebral
blood vessels claudin-3 as well as claudin-1 and -2 are absent in cerebral blood vessels
during all developmental stages up to adulthood. Rather, the BBB is characterized by
the presence of claudin-5, ZO-1 and occludin. Thus, in mice claudin-3 is an important
constituent of TJ in the embryonic and in the adult choroid plexus.
Keywords: blood-brain barrier, claudin-5, tight junctions, zonula occludens, occludin, ependyma, alkaline
phosphatase
INTRODUCTION
The central nervous system (CNS) is tightly sealed from the fluctuating composition
of the blood by the blood-brain barrier (BBB) and the blood-cerebrospinal fluid (CSF)
barrier (BCSFB). The BBB and BCSFB can be localized to highly specialized brain
microvascular endothelial cells and choroid plexus epithelial cells (CPEC), respectively. Besides
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its barrier function, CPECs have a secretory function and
produce the CSF.
The BBB is composed of a monolayer of endothelial cells
surrounded by a basal membrane, pericytes and perivascular
astrocytes (e.g., Haseloff et al., 2005). Highly specialized cerebral
endothelial cells (CECs) form a tight seal but also mediate
the selective transcellular transport of nutrients and other
essential components into the brain, and the efflux of potentially
toxic metabolites from the nervous tissue. CECs allow little
nonspecific transendothelial transport since they exhibit very
low pinocytotic activity (e.g., Brightman and Reese, 1969;
Nitsch et al., 1986), controlled by a transmembrane protein
named Mfsd2a, a member of the major facilitator superfamily,
which is exclusively expressed in CECs (Ben-Zvi et al., 2014).
The paracellular route between individual CECs is sealed by
an elaborate network of complex tight junctions (TJs) that
interconnects endothelial cells. The morphological correlate of
the BCSFB is found at the level of the CPEC, where TJs seal
its apical borders against the CSF (for review, see Vorbrodt and
Dobrogowska, 2003; Wolburg and Paulus, 2010). In Figure 1
the position of the barriers in CEC and CP are schematically
represented and their molecular make-up shown as detailed in
the following paragraphs.
TJs are formed by occludin and claudins, transmembrane
proteins linked to the cytoskeleton through interactions with
accessory proteins, i.e., zonula occludens (ZO-1), -2, and -3.
ZO proteins act as a scaffold for multiple intracellular signaling
pathways and are involved in regulation of TJs function (for
review, see Hawkins and Davis, 2005). Occludin was the
first integral membrane protein described to be exclusively
localized within TJs including the BBB (Furuse et al., 1993) and
to regulate size-selective paracellular diffusion of hydrophilic
molecules (Balda et al., 2000). However, in mice carrying
a null mutation of the occludin gene TJ strands formed
normally (Saitou et al., 2000) suggesting a non-essential
role for occludin in TJ formation. By contrast, transfection
experiments with TJ-free fibroblasts have demonstrated that
claudins, which comprise a gene family of at least 27 members
of integral membrane proteins (Mineta et al., 2011), can
reconstitute membranous strands similar to those observed in
epithelial cells (Furuse et al., 1998). Removal or addition of
claudins generally does selectively affect the barrier functions
of TJs for size and charge. Specific claudins act as sealants,
others form paracellular ion-selective channels (Amasheh
et al., 2002). Furthermore, claudins show a tissue-specific
expression pattern, with a unique combination of claudins
that determine the paracellular tightness and ion-selectivity
(for recent reviews, see Bauer et al., 2014; Markov et al.,
2015).
In brain, claudin-5 was identified as a critical regulator
of capillary endothelial cell permeability (Nitta et al., 2003).
The BBB of claudin-5-deficient mice was permeable in a size-
selective manner. Other claudins, which have been reported
in CECs include claudin-1 (Liebner et al., 2000), claudin-3
(Wolburg et al., 2003) and claudin-12 (Nitta et al., 2003).
Claudin-1, -2 and -11 together with occludin were described in
the CPEC (Wolburg et al., 2001). However, these observations
were challenged by several authors: Kominsky et al. (2007)
reported that claudin-3 was undetectable in CNS tissues with the
exception of the CPEC and Ohtsuki et al. (2008) reported that in
contrast to claudin-5, the mRNA expression levels of claudin-1
and -3 in mouse brain capillary endothelial cells were low and
the involvement of these claudins in TJ formation at the BBB was
likely to be minor.
CECs as well as CPECs play an important role in homeostasis
and composition of the CSF. During development, requirements
for protein and fluid transport fluctuate considerably and this is
governed by the CP and its barrier (Liddelow, 2015). Recent data
show that in rats, CPECs are characterized by claudin-1 (Ghersi-
Egea et al., 2015) and claudin-3 (Kratzer et al., 2012). Similar data
in mice are still lacking.
Knowledge of the development and molecular composition
of cerebral barriers is of major clinical relevance under several
aspects. For example, parasites such as trypanosomes interact
with claudin-1 and -11 at the CPEC resulting in infections of
the CNS (Mogk et al., 2014). In multiple sclerosis (MS) two
different impairments of both CNS barriers are seen: blood-
borne molecules entering the brain due to BBB leakage and the
active migration of inflammatory cells into the CNS (Coisne
and Engelhardt, 2011). In the case of cancer, the trafficking
of metastatic cancer cells into the brain is under control by
CNS barriers (Harhaj and Antonetti, 2004). On the other hand,
permeabilization of CNS barriers would allow the treatment
of intracerebral tumors (Deeken and Löscher, 2007). Finally,
the observation that certain claudins are highly expressed in
certain cancers such as claudin-1 in melanomas (Leotlela et al.,
2007), and claudin-3 and -4 in ovarian, breast, lung and
kidney tumors (Kominsky et al., 2004; Agarwal et al., 2005;
Hewitt et al., 2006) offers the possibility to target the tumors
with anti-claudins. Anti-claudins could, however, if systemically
applied interfere with vital barriers, as the BBB and BCSFB
warranting the need for a better understanding of their molecular
characteristics.
TJ proteins are difficult to localize immunocytochemically.
They are concentrated in cell membranes and confined to the
narrow border that lies between neighboring cells. If the structure
is, in addition, convoluted, as in the case of cerebral microvessels,
only tiny parts of the membranes are exposed in thin sections
and detection becomes even more difficult. This problem can
be overcome by using whole-mounts of brain vessels as in
organotypic slice cultures, e.g., (Bendfeldt et al., 2007), or 3D
reconstruction in thick slices (Paul et al., 2013). A disadvantage
of these approaches is that only limited parts of the tissue can
be scrutinized. Differences in TJ proteins have been analyzed
concerning the different portions of the vascular tree (Paul et al.,
2013). Possible differences in the molecular composition of TJs
in single brain regions have not yet been demonstrated in detail.
Only a very sensitive immunohistochemical staining technique
on thin sections of whole brain might reveal variations in protein
expression.
In view of the importance of determining the precise tissue
localization of TJ proteins in brains of the adult and developing
mouse we aimed to develop a sensitive immunohistochemical
staining protocol which allows the study of the localization of TJ
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FIGURE 1 | Schematic representation of tight junctions (TJs) constituting the blood-brain barrier (BBB) and the BCSFB. (A) At the cerebral blood vessels
TJ strands (green) are arranged at the overlapping parts of neighboring endothelial cells. (B) At the choroid plexus, TJ strands are arranged at the apical parts of the
epithelial cells. (C) TJ strands connecting neighboring cell membranes prevent intercellular transport. (D) The BBB, represented by the red box, is characterized by
claudin-5, a phosphoprotein with four transmembrane domains. It is linked via the scaffolding protein ZO1 to proteins of the cytoskeleton such as actin.
(E) The BCSFB, represented by the green box, is characterized by claudin-3, which acts as a sealant, as does claudin-5. (F) Occludin, a tetra span transmembrane
protein with two large extracellular loops is a obligatory member of TJ strands, as presented by the black box. (G) Claudin-2, a member of the TJs in BCSFB, is a
paracellular H2O and cation channel.
proteins in frozen sections of whole brains. We show here that,
in addition to claudin-1 and claudin-2, claudin-3 is present in
CPECs but absent in CECs. Preliminary data from this studywere
presented in Nitsch et al. (2011).
MATERIALS AND METHODS
Animal experiments were carried out in accordance with the
European Communities Council Directive of 24 November
1986 (86/609/EEC) and were reviewed and permitted by Swiss
authorities and surveyed by the cantonal veterinary office
(project 2064). C57BL/6J mice from embryonic day (E)
14 to adult were used. Embryos (E14, E16 and E18) were
collected from mothers that had been killed quickly by
decapitation. Adult and postnatal day (P) 2, P4, P6, and
P10 mice were decapitated. All animals entering this study
were unperfused since we had observed in previous studies
that perfusion impaired the maintenance of the barrier markers
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(Steinemann and Nitsch, unpublished observation). Whole
heads (from E14 to P6 mice) were frozen in isopentane
(Sigma-Aldrich, St. Louis, MO, USA) at −50◦C. From P10
and adult animals, brains were rapidly removed from the skull,
directly embedded in Tissue-Tek and snap-frozen in isopentane
at −50◦C and stored at −20◦C. Fifteen micrometer (µm)
thick sections of unfixed tissue were obtained at a cryostat
temperature of −24◦C and placed on Super Frost Plus slides
(Menzel-Glaeser, Braunschweig, Germany) and dried over night
at room temperature.
To enhance the detection sensitivity for immunoreactions
we used alkaline phosphatase for detection and modified the
fixation protocol in order to eliminate endogenous phosphatase
activity. Mounted sections were immersion-fixed at pH 11.0
in 4% paraformaldehyde containing 20 mM Na-EDTA for 1 h
at RT, followed by defatting/permeabilization through graded
methanol in Imidazole Buffered Saline (IBS) consisting of 20mM
imidazole in 0.9% NaCl at pH 7.4 (100% methanol for 30 min,
80% methanol/20% IBS for 10 min, 60% methanol/40% IBS for
10 min).
Afterwards, sections were immunoblocked with 3%
bovine serum albumin (BSA), 1% normal goat serum, 0.25%
methylamine, 0.2% Triton X-100 in IBS for 30 min. Primary and
secondary antibodies were diluted 1:100 in the same solution.
Primary antibodies (rabbit polyclonal anti-claudin-1, -claudin-2,
-claudin-3, -claudin-5, -occludin and -ZO-1) from Invitrogen-
Zymed, Switzerland and anti-laminin from Sigma-Aldrich
were incubated overnight at 4◦C. Following washes in IBS,
sections were incubated with goat anti-rabbit IgG conjugated
with alkaline phosphatase (Jackson ImmunoResearch, Roche,
Switzerland) as secondary antibody for 2 h at room temperature.
Immunoreaction was visualized with a BCIP/NBT alkaline
phosphatase substrate system (0.57 mM BCIP, 0.30 mMNBT) in
AMPD buffer (5 mM MgCl2, 100 mM NaCl, 50 mM 2-Amino-
2-methyl-1,3-propanediol adjusted to pH 9.5 with 1 M HCl) at
room temperature for 10 min.
For controls, the primary antibody was omitted. In addition,
the specifity of antibodies was tested on homogenates of mouse
brain or rat liver using our high-resolution SDS electrophoresis
system (Maly and Nitsch, 2007; Maly and Landmann, 2008).
For detection of endogenous activity of alkaline phosphatase,
cryosections were fixed in 4% paraformaldehyde in PBS at pH 7.4
for 30 min at room temperature, rinsed with AMPD buffer and
incubated with BCIP/NBT alkaline phosphatase substrate system
for 10 min.
After washing with PBS for 5 min and dehydration in ethanol
for 10 min, sections were coverslipped in Mowiol and viewed on
a Nikon Eclipse E800 microscope equipped with a ProgRes C 14
plus camera (Jenoptik, Jena, Germany). Pictures were taken using
the image capture software ProgRes Capture Pro 2.5.
RESULTS
In the present study, a BCIP/NBT alkaline phosphatase based
immunohistochemistry staining protocol was used to probe
for the presence of TJ proteins in frozen sections of the
developing and adult mouse brain. To block endogenous
alkaline phosphatase activity, sections were fixed in
4% paraformaldehyde/Na-EDTA solution at pH 11.0. Our
initial experiments showed that, in fact, at pH 11, adequate
fixation of brain sections resulted in good structural preservation
of the nervous tissue. At this high pH, paraformaldehyde in
combination with EDTA completely inactivated endogenous
alkaline phosphatase activities in whole heads of embryonic mice
and in brains of adult mice (Figure 2). This pretreatment did
not impair immunoreactivity of common markers as shown
here for laminin, a marker for the basal lamina (see Figure 4C).
This allowed us to use the highly sensitive alkaline phosphatase
detection method to visualize the presence of TJ proteins.
In the prenatal brain, occludin immunoreactivity was found
in intraparenchymal blood vessels, in the meninges and in the
choroid plexus but not in the ependyma for E14 (Figure 3A)
and E18 (Figure 3D). ZO-1 was present in CECs, the
neuroepithelium of the ventricles (i.e., the choroid plexus and
ependyma), and in themeninges covering the surface of the brain
(Figures 3B,E). Of the claudins tested, only claudin-5 showed
strong selective immunoreactivity in CECs (Figures 3C,F);
localized along intracerebral and pial vessels that were on their
way to the brain. Claudin-1, -2, and -3 were absent from
endothelial cells but could be detected in the epithelium of
the choroid plexus. Strong immunoreactivity was present for
claudin-3 from E14 onward in the choroid plexus (Figures 3I,M),
while claudin-1 was faintly stained (Figure 3G) and claudin-2
was absent (Figure 3H) at the early embryonic stages. At
E18, additionally to claudin-1 and -3, immunoreactivity for
claudin-2 was detected in the choroid plexus and at this stage of
development, the staining intensity of claudin-1, claudin-2 and
claudin-3 were similar (Figures 3K–M).
In high magnification of the choroid plexus it became
evident that claudin-5, if at all present, was situated in
blood vessels of the plexus parenchyma and not in the
plexus epithelium (Figures 4A,B), in contrast to claudin-1,
-2, and -3. The analysis of early development from E14 to
P4 showed a characteristic time pattern of expression for
each of these claudins. The immunoreactivity of claudin-3
remained relatively constant during all ages and with all batches
tested (Figures 4F,I,M,P), while claudin-1 and -2 gave more
variable results. Claudin-1 was present at E14 (Figure 4D), then
increased in expression during development (Figure 4G), peaked
around birth (Figure 4K) and declined towards adulthood
(Figure 4N). Claudin-2 was not yet detectable at E14 (Figure 4E),
present at E18 (Figure 4H) and exhibited at postnatal age a
massive increase (Figures 4L,O) that persisted during further
development at P6 and P10 (not shown) well into the adult brain
(Figures 5E, 6C).
In adult brain (Figures 5, 6), claudin-2, and -3 were
clearly detectable in the epithelium of the choroid plexus.
Neither claudin-1, -2 or -3 antibodies stained CECs. As
previously demonstrated by others, claudin-5 was present in
endothelial cells of the cerebral vasculature and occasionally
in endothelial cells of the choroid plexus but not in its
epithelium (Figures 5C, 6A). Occludin (Figure 5A) and to a
lesser extent ZO-1 (Figure 5B) were expressed in CEC and the
epithelium of the choroid plexus. Claudin-3 was restricted to
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FIGURE 2 | Endogenous alkaline phosphatase activity and its blockage. After fixation of cryosections under standard conditions (4% paraformaldehyde/PBS
pH 7.4) intense staining of AP in meninges and in the parenchyma of developing brain is shown in a horizontal section through the whole head of an E18 embryo (A).
In the adult brain, AP staining is observed in choroid plexus (green arrows) and in blood vessels (red arrows) as shown here in a parasagittal section (C).
Cryosections under alkaline fixation condition in the presence of EDTA (4% paraformaldehyde/20 mM Na-EDTA, pH 11.0), completely inactivates endogenous
alkaline phosphatase activities in the embryonic head (B), where only pigmented structures such as the iris—see blue arrow—and the choroid of the eye bulb give a
dark appearance and in the adult brain (D). Scale bar = 0.5 mm in (A) applies also for (B–D).
the junctions between the epithelial cells of the choroid plexus
(Figures 5C, 6A) and claudin-2 was found not only between the
CPEC but outlining the neuroepithelial cells of the ependyma
(Figures 5E, 6C).
DISCUSSION
Based on the cellular structure of barriers, be they epithelial as
in the case of the BCSFB or endothelial as in the case of the BBB,
presence of TJ proteins is difficult to verify under compound light
microscopy. They form narrow lines between neighboring cells
and in case of the convoluted intracerebral vessels, only small
parts of the structure are present in thin sections. As a result
of this low antigen content the use of a detection system that
is more sensitive than immunofluorescence or the horseradish
peroxidase detection systems is necessary. Such a system exists
in the form of the BCIP/NBT alkaline phosphatase based
immunohistochemical staining protocol (De Jong et al., 1985)
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FIGURE 3 | Immunohistochemical stainings of horizontal cryosections of the developing brain (E14 and E18). Occludin immunoreactivity (A,D) is present
in brain vessels and in epithelium of choroid plexus and ZO-1 (B,E) in brain vessels and in the neuroepithelium of the ventricle. Claudin-5 immunoreactivity (C,F) is
selectively present in the endothelium of brain vessels. Anti-claudin-1 (G,K), anti-claudin-2 (H,L) and anti-claudin-3 (I,M) do not stain any blood vessels but the
epithelium of the choroid plexus. Immunoreactivity for claudin-3 is strong from E14 onward, for claudin-1 faint at E14 and comparable with claudin-3 at E18, and for
claudin-2 it only appears at E18. LV, lateral ventricle; Hi, Hippocampus, green arrow choroid plexus, red arrow blood vessel, black arrow ependyma. Scale
bar = 100 µm in (A) applies also for (B–M).
which due to the absence of H2O2 has the advantage of being
more gentle, so that development can be carried out over hours
if necessary. This alkaline phosphatase staining system has been
adapted here to probe for the distribution of TJ proteins in frozen
sections of unperfused developing and adult brains.
To block endogenous alkaline phosphatase activity, sections
were fixed in 4% paraformaldehyde/Na-EDTA solution at
pH 11.0. This basic fixation pH was recommended for the
localization of tyrosine hydroxylase in the dopaminergic system
of rat brains (Berod et al., 1981). Our initial experiments showed
that in fact, at pH 11.0, adequate fixations of brain sections were
obtained. At this alkaline pH, paraformaldehyde in combination
with EDTA completely inactivated endogenous alkaline
phosphatase activities in brain and bone. Immunoreactions
for well-documented tissue markers such as GFAP (astrocyte
marker, not shown) and laminin gave results indistinguishable
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FIGURE 4 | High magnification of the choroid plexus in the lateral ventricle during embryonic and early postnatal development. (A,B) Claudin-5 heavily
stains the blood vessels in the brain parenchyma and in the choroid plexus, but not the epithelium of choroid plexus. (C) The marker for the basal lamina, laminin, is
outlining the border between CPECs and CP parenchyma, as well as the borders of the intracerebral vessels. (D–P) Claudin-1, claudin-2 and claudin-3 are
expressed in epithelial cells of the choroid plexus with varying density at different developmental stages. Endothelial cells of blood vessels, however, never express
claudin-1,-2 or -3. Green arrow choroid plexus. Scale bar = 100 µm in (A) applies also for (B–P).
to other fixation protocols. Using this immunohistochemical
staining protocol, we could confirm previous data on the
molecular make-up of the BBB during development and in
the adult rodent (see Ballabh et al., 2004; Abbott et al., 2010):
occludin, ZO-1 and claudin-5 were expressed in CECs from
early embryonic age on into adulthood. No clear differences
between brain regions were found. While occludin and to a
lesser extent ZO-1 were present in the epithelia of the BCSFB,
claudin-5 was found exclusively in blood vessels, occasionally
also labeling vessels in the stroma of CP, but never in the
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FIGURE 5 | Immunocytochemistry of choroid plexus in the fourth
ventricle on sagittal cryosections of adult mouse brain.
Immunoreactivity for occludin (A) is present in blood vessels and in the apical
parts of the plexus epithelium as well as the ependyma. ZO-1 (B)
immunoreactivity is relatively faint in the adult and labels blood vessels, basal
parts of the plexus epithelium and the ependyma. Claudin-5 (C) is selectively
and strongly labeling brain blood vessels. It is absent from the plexus
epithelium and the ependyma. Immunoreactivity for claudin-1 (D), Claudin-2
(E) and claudin-3 (F) is absent from the brain vessels. The immunoreactivity
against claudin-1 in CP is weak compared to immunoreactivities against
claudin-2 and -3. Scale bar = 100 µm in (A) applies also for (B–F).
epithelium. Claudin-5 is responsible for the size-selective barrier
at the BBB (Nitta et al., 2003; Coisne and Engelhardt, 2011)
playing a key role in BBB development and maintenance as well
as being lethal by the lack of it (Coisne and Engelhardt, 2011).
Neither claudin-1 nor -2 and -3 were detectable in cerebral
vessels, but from the early embryonic age on in CPECs. Claudin-1
and -2 had previously been detected in the choroid plexus
(Lippoldt et al., 2000), but claudin-3 has been referred to as a key
molecule of the TJ of the BBB and considered to be responsible
for their tightness (Wolburg et al., 2003). Recent data in humans
and mice suggest, however, that claudin-3 is undetectable in
CNS tissue with the exception of the CP (Kominsky et al., 2007;
Ohtsuki et al., 2008). Similar to our findings, Kooij et al. (2014)
FIGURE 6 | High magnification of immunocytochemistry of choroid
plexus in the fourth ventricle on sagittal cryosections of adult mouse
brain. Immunoreactivity for claudin-5 (A) is only present in blood vessels, in
intracerebral vessels as well as in an occasional intraparenchymal vessel of the
choroid plexus. Claudin-3 (B) is restricted to the epithelium of choroid plexus
and claudin-2 (C) is in the epithelium of the choroid plexus and the ependyma.
Green arrow choroid plexus epithelial cell, red arrow endothelium of blood
vessels, black arrow ependyma. Scale bar = 50 µm in (A) applies also for
(B,C).
showed a restricted protein expression of claudin-3 in CPECs
with a typical TJ strand arrangement in adult mouse and human
brain tissue. Also, Kratzer et al. (2012) demonstrated this for
claudin-1, -2 and -3 in rat CPECs.
Throughout development the immunoreactivity patterns of
claudins at the choroid plexus underwent marked changes. At
E14, claudin-3 was most prominent at CPECs while claudin-2
immunoreactivity was absent. At E-18, a similar staining
intensity of claudin-1, -2 and -3 were observed. In adult brain,
however, immunoreactivity of claudin-1 was diminished and
immunoreactivity of claudin-2 was strong in CPECs. In contrast,
the immunoreactivity of claudin-3 in CPECs remained relatively
constant during all ages tested. Kratzer et al. (2012) demonstrated
by rtPCR and Western blot in the developing rat brain and
by immunohistochemistry in pre- and postnatal human brain
the expression of claudin-1, -2 and -3 at CPECs. Similar to
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our observations, they found that claudin-1 is upregulated at
embryonic stages and that claudin-2 was continuously increasing
with age. In rats, claudin-3 was detected at all stages but
down-regulated in adult animals. However, in mice as shown
in the present study there was a strong immunoreaction for
claudin-3 in all ages. These divergent findings might be explained
by the use of Western blot and rtPCR, in comparison to
immunohistochemistry.
Overall, the composition of the CSF-barrier seems to be
dynamic and constantly changing during the development, likely
reflecting the different demands of the developing brain for
proteins and fluid volume and composition (Ghersi-Egea et al.,
2015; Liddelow, 2015). Thus, claudins-1 and -3 with sealing
function behave differently from claudin-2 which functions as
water and cation channel (Yu et al., 2009; Rosenthal et al., 2010).
For MS, understanding the contribution of the different claudins
in neuroinflammation and the role of claudin-3 in BCSF (Kooij
et al., 2014) is of relevance.
Finally, besides the superior sensitivity, the
immunocytochemical technique presented here has an
additional advantage: whole brain sections can be analyzed
at high and low magnification to study regional variation in
protein expression. While we did not observe major differences
in the expression of TJ proteins between brain regions in normal
healthy brain, this might be quite different under experimental
conditions and in the diseased brain from stroke to MS.
Furthermore, claudin-3 and -4 were identified as receptors for
cytotoxic Clostridium perfringens enterotoxin (CPE, Katahira
et al., 1997). The ability of CPE to rapidly and specifically
lyse cells expressing claudin-3 and/or -4 might be useful for
the treatment of tumors expressing these claudins (see Black
et al., 2015). However, an important concern for any new drug
therapy is systemic toxicity, since many other tissues express
claudins. Determining the presence or absence of claudins is
invaluable, especially on their localization at the barriers of
the brain and can now be reliably tested using the present
method.
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